{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-09-25",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "product_ndc": "68462-329",
      "generic_name": "Trandolapril and Verapamil Hydrochloride",
      "labeler_name": "Glenmark Pharmaceuticals Inc., USA",
      "brand_name": "Trandolapril and Verapamil Hydrochloride",
      "active_ingredients": [
        {
          "name": "TRANDOLAPRIL",
          "strength": "4 mg/1"
        },
        {
          "name": "VERAPAMIL HYDROCHLORIDE",
          "strength": "240 mg/1"
        }
      ],
      "finished": true,
      "packaging": [
        {
          "package_ndc": "68462-329-01",
          "description": "100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-01)",
          "marketing_start_date": "20150225",
          "sample": false
        },
        {
          "package_ndc": "68462-329-10",
          "description": "1000 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (68462-329-10)",
          "marketing_start_date": "20150225",
          "sample": false
        }
      ],
      "listing_expiration_date": "20271231",
      "openfda": {
        "manufacturer_name": [
          "Glenmark Pharmaceuticals Inc., USA"
        ],
        "rxcui": [
          "897781",
          "897783",
          "897844",
          "897853"
        ],
        "spl_set_id": [
          "39bad727-af4c-4d20-933b-7f287e88099a"
        ],
        "is_original_packager": [
          true
        ],
        "upc": [
          "0368462294017",
          "0368462329016"
        ],
        "nui": [
          "N0000175562",
          "N0000000181"
        ],
        "pharm_class_epc": [
          "Angiotensin Converting Enzyme Inhibitor [EPC]"
        ],
        "pharm_class_moa": [
          "Angiotensin-converting Enzyme Inhibitors [MoA]"
        ],
        "unii": [
          "1T0N3G9CRC",
          "V3888OEY5R"
        ]
      },
      "marketing_category": "ANDA",
      "dosage_form": "TABLET, FILM COATED, EXTENDED RELEASE",
      "spl_id": "770b4914-a475-4841-83f8-79261f115eff",
      "product_type": "HUMAN PRESCRIPTION DRUG",
      "route": [
        "ORAL"
      ],
      "marketing_start_date": "20150225",
      "product_id": "68462-329_770b4914-a475-4841-83f8-79261f115eff",
      "application_number": "ANDA079135",
      "brand_name_base": "Trandolapril and Verapamil Hydrochloride",
      "pharm_class": [
        "Angiotensin Converting Enzyme Inhibitor [EPC]",
        "Angiotensin-converting Enzyme Inhibitors [MoA]",
        "Calcium Channel Antagonists [MoA]",
        "Calcium Channel Blocker [EPC]",
        "Cytochrome P450 3A Inhibitors [MoA]",
        "Cytochrome P450 3A4 Inhibitors [MoA]",
        "P-Glycoprotein Inhibitors [MoA]"
      ]
    }
  ]
}